GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (XBRU:ONWD) » Definitions » Debt-to-Asset

Onward Medical NV (XBRU:ONWD) Debt-to-Asset : 0.39 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Onward Medical NV Debt-to-Asset?

Onward Medical NV's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.57 Mil. Onward Medical NV's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €16.31 Mil. Onward Medical NV's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was €43.63 Mil. Onward Medical NV's debt to asset for the quarter that ended in Dec. 2023 was 0.39.


Onward Medical NV Debt-to-Asset Historical Data

The historical data trend for Onward Medical NV's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onward Medical NV Debt-to-Asset Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial 1.45 2.96 0.13 0.19 0.39

Onward Medical NV Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.15 0.19 0.27 0.39

Competitive Comparison of Onward Medical NV's Debt-to-Asset

For the Biotechnology subindustry, Onward Medical NV's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Onward Medical NV's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onward Medical NV's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Onward Medical NV's Debt-to-Asset falls into.



Onward Medical NV Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Onward Medical NV's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.568 + 16.306) / 43.629
=0.39

Onward Medical NV's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.568 + 16.306) / 43.629
=0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Onward Medical NV  (XBRU:ONWD) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Onward Medical NV Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Onward Medical NV's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Onward Medical NV (XBRU:ONWD) Business Description

Traded in Other Exchanges
Address
High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.

Onward Medical NV (XBRU:ONWD) Headlines

No Headlines